Elizabeth C. Goode

2.0k total citations · 1 hit paper
9 papers, 1.2k citations indexed

About

Elizabeth C. Goode is a scholar working on Epidemiology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Elizabeth C. Goode has authored 9 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Epidemiology, 3 papers in Surgery and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Elizabeth C. Goode's work include Liver Diseases and Immunity (3 papers), Liver Disease Diagnosis and Treatment (2 papers) and Glycosylation and Glycoproteins Research (1 paper). Elizabeth C. Goode is often cited by papers focused on Liver Diseases and Immunity (3 papers), Liver Disease Diagnosis and Treatment (2 papers) and Glycosylation and Glycoproteins Research (1 paper). Elizabeth C. Goode collaborates with scholars based in United Kingdom, United States and Australia. Elizabeth C. Goode's co-authors include Trevor C. McMorris, Daniel J. Noonan, William W. Lamph, Barry M. Forman, Ronald M. Evans, Jasmine Chen, David J. Bradley, Thomas Perlmann, Cary Weinberger and Leo T. Burka and has published in prestigious journals such as Cell, Nature Communications and Blood.

In The Last Decade

Elizabeth C. Goode

9 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Identification of a nuclear receptor that is activated by farnesol metabolites

1995 989 citations Barry M. Forman, Elizabeth C. Goode et al. Cell profile →

Peers

Countries citing papers authored by Elizabeth C. Goode

Since Specialization

Citations

This map shows the geographic impact of Elizabeth C. Goode's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth C. Goode with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth C. Goode more than expected).

Fields of papers citing papers by Elizabeth C. Goode

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth C. Goode. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth C. Goode. The network helps show where Elizabeth C. Goode may publish in the future.

Co-authorship network of co-authors of Elizabeth C. Goode

This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth C. Goode. A scholar is included among the top collaborators of Elizabeth C. Goode based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth C. Goode. Elizabeth C. Goode is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

#	Work	Indexed citations
1	Fine-mapping and molecular characterisation of primary sclerosing cholangitis genetic risk loci 2024 ·Nature Communications ·Elizabeth C. Goode, Laura Fachal, Nikolaos Panousis, Loukas Moutsianas, Rebecca E. McIntyre, (unknown), Norihito Kawasaki, Alexandra Wittmann, Tim Raine, Simon Rushbrook, Carl A. Anderson	1
2	A review of the medical treatment of primary sclerosing cholangitis in the 21st century 2015 ·Therapeutic Advances in Chronic Disease ·Elizabeth C. Goode, Simon Rushbrook	31
3	O080 : Early clinical features associated with long-term risk of transplantation in primary sclerosing cholangitis: Results from the UK-PSC consortium 2015 ·Journal of Hepatology ·Elizabeth C. Goode, (unknown), Allan Clark, (unknown), Gideon M. Hirschfield, William Gelson, (unknown), George Mells, Richard Sandford, Graeme Alexander, Roger W. Chapman, (unknown)	3
4	Haemoptysis from a pulmonary arteriovenous malformation in a post molar pregnancy gestational trophoblast tumour patient managed by radiological embolisation: a case report 2014 ·Journal of Medical Case Reports ·(unknown), (unknown), Elizabeth C. Goode, Candice Clarke, James E. Jackson, Michael J. Seckl, Philip Savage	6
5	A Rare Cause of Cholangiopathy 2013 ·Gastroenterology ·Elizabeth C. Goode, (unknown), Simon Rushbrook	7
6	Specific N-linked glycosylation sites modulate synthesis and secretion of von Willebrand factor 2010 ·Blood ·Thomas A. J. McKinnon, Elizabeth C. Goode, Graeme M. Birdsey, Agata Nowak, A.C.K. Chan, David A. Lane, Michael Laffan	46
7	Early Elevation of Soluble CD14 May Help Identify Trauma Patients at High Risk for Infection 2001 ·Eddy H. Carrillo, Laura Gordon, Elizabeth C. Goode, (unknown), Hiram C. Polk	25
8	Identification of a nuclear receptor that is activated by farnesol metabolites breakdown → 1995 ·Cell ·Barry M. Forman, Elizabeth C. Goode, Jasmine Chen, Anthony E. Oro, David J. Bradley, Thomas Perlmann, Daniel J. Noonan, Leo T. Burka, Trevor C. McMorris, William W. Lamph, Ronald M. Evans, Cary Weinberger	989
9	Four-Year Follow-up of Mortality and Sleep-Related Respiratory Disturbance in Non-Demented Seniors 1995 ·SLEEP ·Andrea Mant, Madeline King, Nicholas A. Saunders, Constance Dimity Pond, Elizabeth C. Goode, (unknown)	69

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact